Target intelligence / Profile preview

microRNA 3150b (MIR3150B)

Target
MIR3150B
Molecular classification
microRNA, Non-coding RNA, RNA gene, Post-transcriptional gene regulator
01

Overview

**MicroRNA 3150b (MIR3150B)** is a small (20–24 nucleotide) non-coding RNA classified as a microRNA (miRNA) that regulates gene expression post-transcriptionally, primarily by binding to target mRNAs and causing their translational repression or destabilization[1]. The MIR3150B gene gives rise to mature miRNAs, most notably miR-3150b-3p, which can modulate various biological processes by targeting specific mRNAs for gene silencing. MIR3150B has been implicated in several cancers, including non-small cell lung carcinoma, where it is believed to inhibit cell proliferation[6], and in diffuse large B-cell lymphoma, where its expression may serve as a biomarker for disease subtype and prognosis[5]. Like other miRNAs, it is generated from a stem-loop precursor via the action of Drosha and Dicer enzymes before participating in regulatory complexes that modulate gene expression. The gene does not encode a protein and currently has no known drug inhibitors or targeted therapies, but its disease association suggests possible utility as a biomarker or indirect therapeutic target[1][5][6].

Other names
hsa-mir-3150bmir-3150bMIR3150Bhsa-miR-3150b-3p
02

Mechanism of action

Gene silencing via RNA-induced silencing complex (RISC); Translational inhibition or mRNA destabilization

03

Biological functions

Post-transcriptional regulation of gene expressionInhibition of cell proliferation (notably in non-small cell lung carcinoma)Regulation of mRNA translation and stabilityPotential involvement in cell cycle regulation
04

Disease associations

CancerNon-small cell lung carcinoma (NSCLC)Diffuse large B-cell lymphoma (DLBCL), especially germinal center B-cell like subtype
05

Biomarkers

miR-3150b-3p expression as potential biomarker for diagnosis, classification, prognosis, and treatment response in diffuse large B-cell lymphoma (DLBCL)[5]miR-3150b-3p expression may act as a prognostic or disease activity marker in NSCLC[6]

Beyond the preview

Go deeper on microRNA 3150b (MIR3150B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 3150b (MIR3150B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call